Ghrelin and its role in health and disease


Cite item

Full Text

Abstract

The paper provides a review of the present-day literature on the role of the hormone ghrelin discovered in 1999.

Full Text

Грелин и его роль в норме и патологии. - Аннотация. Представлен обзор современной литературы о роли гормона грелина, открытого в 1999 г.
×

About the authors

I V Tereshchenko

P E Kaiushev

References

  1. Kojima M., Hosoda H., Date Y. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
  2. Mori K., Yoshimoto A., Takaya K. et al. Kidney produces a novel acylated peptide, ghrelin FEBS Lett 2000; 486 (3): 213-216.
  3. Панков Ю.А. Революционные перемены в эндокринологии. Пробл эндокринол 2005; 6: 3-8.
  4. Васюкова О.В., Витебская А.В. Грелин: биологическое значение и перспективы применения в эндокринологии. Пробл эндокринол 2006; 2: 3-7.
  5. Date Y., Kojima M., Hosoda H. et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-4261.
  6. Chiesa C., Osborn J.F., Pacifico L. et al. Circulation Ghrelin in patients undergoing elective cholecystectomy. Clin Chem 2005; 51 (7): 1258-1261.
  7. Парфенов А.И. Грелин и пептид YY - регуляторы аппетита и количества потребляемой пищи. Перспективы лечения кахексии и ожирения. Тер арх 2005; 2: 92-94.
  8. Wu J.T., Kral J.G. Ghrelin: integrative neuroendocrine peptide in health and disease. Ann Surg 2004; 239: 464-474.
  9. Fuglsang J., Skjaebaek C., Espelund U. et al. Ghrelin and its relationship to growth hormones during normal pregnancy. Clin Endocrinol (Oxf) 2005; 62 (5): 554-559.
  10. Tena-Sempere M. Roles of ghrelin and leptin in the control of reproductive function. Neuroendocrinol 2007; 86: 229-241.
  11. Gualillo O., Caminos J., Blanco M. et al. Ghrelin, a novel placental-derived hormone. Casanueva Endocrinol 2001; 142 (2): 788-794.
  12. Kheradmand А., Alirezaei M., Asadian P. et al. Antioxidant enzyme activity and MDA level in the rat testis following chronic administration of ghrelin. Andrologia 2009; 41 (6): 335-340.
  13. Bennett N.R., Boyne M.S., Cooper R.S. et al. Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change. Clin Endocrinol 2009; 70 (3): 408-414.
  14. Meier U., Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 2004; 50: 1511-1525.
  15. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A. et al. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002; 146 (2): 241-244.
  16. Dixit V.D., Schaffer E.M., Pale R.S. et al. Ghrelin inhibits leptin and activation-induced proinflammatory cytokine expression by human monocytes and T-cells. J Clin Inv 2004; 114: 57-66.
  17. Murdolo G., Lucidi P., Di Loreto C. et al. Insulin is required for prandial ghrelin suppression in humans. Diabetes 2003; 52 (12): 2923-2927.
  18. Mohlig M., Spranger J., Otto B. et al. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 2002; 25 (11): 3638.
  19. Monteleone P., Bencivenga R., Longobardi N. et al. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J Clin Endocrinol Metab 2003; 88 (11): 5510-5514.
  20. Орлова Е.Г., Ширшев С.В. Регуляция лептином и грелином экспрессии мембранных молекул и апоптоза лимфоцитов человека при беременности. Пробл эндокринол 2010; 3: 26-30.
  21. Chan J.L., Bullen J., Lee J.H. et al. Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 2004; 89: 335-343.
  22. Schofl C., Horn R., Schill T. et al. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87 (10): 4607-4610.
  23. Espelund U., Hansen T.K., Hojlund K. et al. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. J Clin Endocrinol Metab 2005; 90: 741-746.
  24. Whatmore A.J., Hall C.M., Jones J. et al. Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol (Oxf) 2003; 59 (5): 649-654.
  25. Wierup N., Yang S., McEvilly R.J. et al. Ghrelin is expressed in a Novel Endocrine Cell Type in developing Rat Islets and Inhibits Insulin Secretion from INS-1 (832/13) Cells. J Hystoche Cytochem 2004; 52 (3): 301-310.
  26. Mendes-Sanches N., Ponciano-Rodrigues G., Bermegjo-Martines L. et al. Low serum levels of ghrelin are assosiated with gallstone disease. World J Gastroenterol 2006; 12 (19): 3096-3100.
  27. Nagaya N., Kojima M., Uematsu M. et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Physiol 2001; 280 (5): 1483-1487.
  28. Okumura E.L., Nagaya N., Enomoto M. et al. Vasodilatoiy effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 2002; 39 (6): 779-783.
  29. Hattori N., Saito. T., Yagyu T. et al. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T-cells, B-cells, and neutrophils. J Clin Endocrinol Metabol 2001; 86: 4284-4291.
  30. Wasseem T., Duxbury M., Ito H. et al. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 2008; 143: 334-342.
  31. van der Lely A.J., Tschop M., Heiman M.L., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004; 25 (3): 426-457.
  32. Cummings D.E., Shannon M.H. Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 2003; 138: 389-396.
  33. Tschop M., Weyer C., Tataranni P.A. et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709.
  34. Tschop M., Wawarta R., Riepl R.L. et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001; 24: 19-21.
  35. Guo Z.F., Zheng X., Qin Y.W. et al. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 2007; 92 (5): 1875-1880.
  36. Langenberg C., Bergstrom J., Laughlin C.A. et al. Ghrelin and the metabolic syndrome in older adalts. J. Clin. Endocrinol. Metab. 2005; 90: 6448-6453.
  37. Вербовой А.Ф., Решетова О.Н. Грелин и гормонально-метаболические показатели у юношей с ожирением и избыточной массой тела. Пробл эндокринол 2009; 2: 23-26.
  38. Kanumakala S., Greaves R., Pedreira С.C. et al. Fasting ghrelin levels are not elevated in children with hypothalamic obesity. J Clin Endocrinol Metab 2005; 90 (5): 2691-2695.
  39. Pöykkö S.M. Ghrelin, metabolic risk factors and carotid artery athersclerosis. Acta Univ Ouluen 2005; 816: 91-93.
  40. Pöykkö S.M., Kellokoski E., Hörkkö S. et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52 (10): 2546-2553.
  41. Otto B., Cuntz U., Fruehauf E. et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001; 145: 669-673.
  42. Engstrom B.E., Burman P., Holdstock C., Karlsson F.A. Effects of growth hormone (GH) on ghrelin, leptin and adiponectin in GH-deficient patients. J Clin Endocrinol Metab 2003; 88 (11): 5193-5198.
  43. Korbonits M., Kojima M., Kangawa K., Grossman A.B. Presence of ghrelin in normal and adenomatous human pituitaiy. Endocrine 2001; 14 (1): 101-104.
  44. Сetinkaya Z., Aydin S., Cerrahoglu Y.Z. et al. Changes in appetite hormone (ghrelin) levels of saliva and serum in acute appendicitis cases before and after operation. Appetite 2009; 52 (1): 104-107.
  45. Каюшев П.Е., Терещенко И.В. Роль грелина при хирургическом стрессе. Онкология - ХХI век. Матер. VI (XV) Междунар. науч. конф. по онкологии. Пермь: Книжный формат 2011: 175-180.
  46. Терещенко И.В., Каюшев П.Е. Секреция грелина у больных, оперированных по поводу желчно-каменной болезни. Хирургия 2011; 10: 39-42.

Copyright (c) 2013 Tereshchenko I.V., Kaiushev P.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies